Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials
| Date first appeared online | 24/11/2018 |
| DOI | 10.1007/s13300-018-0531-0 |
| Authors | Bain S. |
| Journal Name | Diabetes Therapy |
| Volume | 10 |
Documents
- 45467v2.pdf , Book, Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).